Literature DB >> 7639446

Severe osteoporosis in men.

N Kelepouris1, K D Harper, F Gannon, F S Kaplan, J G Haddad.   

Abstract

OBJECTIVE: To evaluate men with severe osteoporosis for pathogenetic factors and to review the reported features of primary osteoporosis in men.
DESIGN: Case series and clinical review. PATIENTS: 47 men consecutively referred to a metabolic bone center because of atraumatic (or minimally traumatic) fractures (91%) or radiographic osteopenia (9%). MEASUREMENTS: Clinical assessment, radiographs, chemical analyses of serum and urine, hormone assays, skeletal densitometry, and histomorphometry of iliac crest biopsy specimens.
RESULTS: 27 of the 47 men (57%) had vertebral fractures, and 16 (34%) had appendicular fractures. Causal factors identified in 30 men (64%) included glucocorticosteroid treatment (8 men); hypogonadism (7 men); excessive alcohol consumption (7 men); and anticonvulsant use, osteomalacia, severe hyperthyroidism, or bone marrow neoplasia (8 men). Seventeen men (36%) had no medical conditions or known risk factors associated with bone disease. Spinal mineral density was well below the mean value for healthy young men in 94% of the patients with primary osteoporosis tested. Examination of biopsy specimens from 13 of 17 men with primary osteoporosis showed reduced trabecular bone volumes, normal bone formation rates, and slightly increased resorption surfaces. Fasting hypercalciuria was seen in some men (41%). In the primary osteoporosis group, eight men were followed serially (range of follow-up, 6 months to 9 years) while they were receiving a nonpharmacologic regimen (diet and activity); the mean axial bone mineral density of these men increased slightly.
CONCLUSIONS: A thorough evaluation for identifiable causes of severe osteoporosis in men is warranted because definable pathogenetic factors are seen in many cases. A few men with severe osteoporosis have primary or idiopathic osteoporosis. Primary osteoporosis in men is probably caused by many factors because heterogeneous clinical, laboratory, and histologic features were seen in our series and in those of others. Further studies of primary osteoporosis are needed to define the course of the disease, to identify pathogenetic mechanisms, and to develop therapeutic interventions.

Entities:  

Mesh:

Year:  1995        PMID: 7639446     DOI: 10.7326/0003-4819-123-6-199509150-00010

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  35 in total

Review 1.  Osteoporosis in men.

Authors:  G M Prelevic
Journal:  J R Soc Med       Date:  2001-12       Impact factor: 5.344

2.  The utility of BMD Z-score diagnostic thresholds for secondary causes of osteoporosis.

Authors:  F E McKiernan; R L Berg; J G Linneman
Journal:  Osteoporos Int       Date:  2010-06-09       Impact factor: 4.507

Review 3.  Male osteoporosis: new trends in diagnosis and therapy.

Authors:  Hosam K Kamel
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 4.  Osteoporotic fractures in older adults.

Authors:  Cathleen S Colón-Emeric; Kenneth G Saag
Journal:  Best Pract Res Clin Rheumatol       Date:  2006-08       Impact factor: 4.098

5.  Lack of biochemical hypogonadism in elderly Arab males with low bone mineral density disease.

Authors:  Haider M Al Attia; Krishnasamy Jaysundaram; Fouad Saraj
Journal:  Rheumatol Int       Date:  2009-06-12       Impact factor: 2.631

6.  Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density.

Authors:  A Cohen; R R Recker; J Lappe; D W Dempster; S Cremers; D J McMahon; E M Stein; J Fleischer; C J Rosen; H Rogers; R B Staron; J Lemaster; E Shane
Journal:  Osteoporos Int       Date:  2011-03-02       Impact factor: 4.507

7.  Vertebral fractures and bone mineral density in idiopathic, secondary and corticosteroid associated osteoporosis in men.

Authors:  S F Evans; M W Davie
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

8.  Age-related changes in bone density among healthy Greek males.

Authors:  G E Krassas; F G Papadopoulou; D Doukidis; T H Konstantinidis; K Kalothetou
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

Review 9.  Management of osteoporosis in the aging male: focus on zoledronic acid.

Authors:  Paul K Piper; Ugis Gruntmanis
Journal:  Clin Interv Aging       Date:  2009-06-29       Impact factor: 4.458

Review 10.  A systematic review and meta-analysis of bone metabolism in prostate adenocarcinoma.

Authors:  Ary Serpa Neto; Marcos Tobias-Machado; Marcos A P Esteves; Marília D Senra; Marcelo L Wroclawski; Fernando L A Fonseca; Rodolfo B dos Reis; Antônio C L Pompeo; Auro Del Giglio
Journal:  BMC Urol       Date:  2010-05-19       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.